Healthy volunteers
Conditions
Interventions
Single intake 40 g of sugarless chocolate.
Single intake 40 g of normal chocolate.
Sponsors
KSO Corporation
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Males and females whose age is no less than 20, less than 65 years old at the time of consent acquisition who have no problem with blood sugar level 2) Subjects receiving a sufficient briefing of the objective and content of the present study, fully understanding and agreeing to voluntarily participate in the study and being able to personally sign a written informed consent
Exclusion criteria
Exclusion criteria: 1) Subjects suffering from serious renal disease, liver disease, heart disease, respiratory disease, endocrine disease, and other metabolic diseases 2) Subjects who take regularly medicines that may affect blood glucose levels 3) Subjects who cannot stop taking supplements, health foods (including food for specified health use, foods with functional claims) that may affect blood glucose levels during the test period 4) Subjects with a history of gastrointestinal diseases and gastrointestinal surgery that affect digestion and absorption (excluding appendicitis) 5) Subjects weighing less than 40 kg 6) Subjects who have food allergies 7) Subjects with a history of drug dependence, alcohol dependence, or current medical history 8) Subjects who are pregnant, are willing to become pregnant during the test period, may be pregnant, are breastfeeding 9) Subjects who cannot stop drinking from 2 days before each test 10) Subjects who have been diagnosed with anemia by screening tests and are not suitable for frequent blood sampling 11) Subjects who have collected more than 200 mL of blood within 1 month or donated more than 400 mL of blood within 3 months from the date of consent acquisition 12) Subjects who are participating in the test of ingesting other foods or using medicines, the test of applying cosmetics and medicines, those who have participated in other clinical trials within one month of obtaining consent, and those who are willing to participate 13) Others who are judged by the investigator to be inappropriate as subjects
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood glucose level, blood glucose level AUC | — |
Secondary
| Measure | Time frame |
|---|---|
| Insulin, neutral fat, active GLP-1 | — |
Countries
Japan
Contacts
Public ContactEiji Yoshikawa
KSO Corporation Sales department
Outcome results
None listed